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Abstract 
Purpose: To examine if dietary intake of foods rich in flavonoids, which have been shown to 
be inversely associated with chronic diseases, is associated with inflammatory processes.  
Methods: This analysis includes controls of case-control studies nested within the Multiethnic 
Cohort (MEC) who completed a validated food frequency questionnaire at cohort entry. 
Biomarkers were assessed in blood donated during follow-up (mean=9.6 years). We used 
multivariate linear regression adjusted for potential confounders to estimate associations 
between intake of flavanones, flavonols, and isoflavones and levels of adiponectin, leptin, C-
reactive protein, interleukin (IL)-1β, IL-6, IL-10 and tumor necrosis factor-α.  
Results: Among the 1,287 participants, the respective median intakes of flavanones, 
flavonols, and isoflavones were 26.5, 12.4, and 1.3 mg/day at cohort entry. With the 
exception of flavanone intake, which was statistically significantly inversely associated with 
adiponectin (p=0.01) and IL-6 concentrations (p=0.01), none of the examined flavonoids was 
related with levels of adipokines or inflammatory markers. Heterogeneity by ethnicity was 
only observed for flavonol intake and IL-10 (pinteraction=0.04) and may be the result of multiple 
testing. These null findings were confirmed in a subset of participants who completed a 
second dietary history within 2.6 years of blood draw. 
Conclusion: The current results do not support a consistent association between dietary 
intake of flavonoids and markers of inflammatory processes. 
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Introduction 
Inflammatory processes are involved in cancer development and progression [1, 2]. Thus, 
factors that influence these processes, such as nutrients with antioxidant capacity, may 
potentially influence cancer risk. Polyphenols are antioxidants found in abundance in fruits, 
vegetables, cereals, dry legumes, chocolate, and beverages, such as tea, coffee, or wine [3]. 
Flavonoids, a subgroup of polyphenols, are classified into the main sub-groups of flavonols, 
flavones, flavanols, flavanones, isoflavones, lignans, anthocyanins and proanthocyanins [4]. 
Whereas experimental studies on animals or cultured human cell lines support a role of 
flavonoids in the prevention of cancers, the associations in human studies are less clear, 
although some studies support their association with the risk of certain types of cancer [5, 6]. 
For example, in a lung cancer case-control study conducted in Hawaii, foods rich in quercetin 
(onions and apples) and naringenin (white grapefruit) were inversely associated with risk for 
certain forms of lung cancer [7]. In the Multiethnic Cohort (MEC), total flavonol intake, and in 
particular, kaempferol, was inversely related to pancreatic cancer [8], and total intake of 
isoflavones, as well as the intake of daidzein and genistein individually, were related to a 
lower endometrial cancer risk [9]. Although it has been speculated that flavonoids might 
influence cancer risk via effects on inflammation [10], so far only a few investigations have 
examined the associations of flavonoid intake with markers of inflammation. The results are 
rather heterogeneous depending on the flavonoids and the inflammatory markers examined, 
as well as on the type of study [11-19]. Almost all studies that analyzed the associations 
between flavonoids and inflammation have been conducted in white populations; only studies 
based on the National Health and Nutrition Examination Survey (NHANES) included non-
Hispanic Blacks and Mexican-Americans but without reporting results by race/ethnicity [16, 
17]. The MEC offers a good opportunity to investigate whether associations between intake of 
flavonoids and inflammatory markers in blood differ across ethnic groups, in particular in 
whites and Asians given their diverse dietary habits and patterns of flavonoid intake. 
Specifically, we examined the intake of isoflavones, found mainly in soy foods, flavonols 
(kaempferol, quercetin, myricetin, commonly found in onions and apples), and flavanones 
(naringenin and hesperitin as found in citrus fruits), which were currently available in our 
food composition database.  
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Material and methods 
Study participants. The MEC is a longitudinal study designed to investigate the association of 
dietary, lifestyle, and genetic factors with the incidence of cancer. The cohort was 
established in Hawaii and Los Angeles in 1993-1996 [20]. Individuals from 5 major ethnic 
groups (whites, Japanese Americans, Latinos, African Americans, and Native Hawaiians) were 
identified primarily through driver’s license files, but also through voter registration lists in 
Hawaii and Medicare files in California. A total of 215,251 men and women aged 45 to 75 
years were included at baseline [20]. All participants completed a self-administered 
questionnaire on diet, anthropometric measures, medical history, and lifestyle. A MEC 
biospecimen subcohort was established in 2001-2006 by asking surviving cohort members to 
provide blood and urine specimens [21]. In total, 67,594 cohort members, broadly 
representative of the full cohort, contributed to the biorepository. During 2003-2007, a full 
questionnaire (Qx3) was completed by approximately 50% of cohort members. The study 
protocol was approved by the Institutional Review Boards of the University of Hawaii and the 
University of Southern California. 
 
Dietary assessment. A validated food frequency questionnaire (FFQ) was used to assess the 
participants' habitual diet in the past year [22]. For selected macro- and micronutrients, the 
correlations with 24-hour recalls were highly satisfactory after energy adjustment, but 
individual foods and nutrients such as flavonoids were not validated separately [22]. Based on 
FFQ information, daily intake of selected flavonoids and total energy intake were computed 
using a food composition table developed and maintained by the University of Hawaii Cancer 
Center [23]. It includes primarily information from the U.S. Department of Agriculture but 
also measurements performed at our institution. For a subset of study participants, updated 
diet information was collected by FFQ as part of Qx3. Flavonoids that were available in the 
nutritional database included flavonols (kaempferol, quercetin, myricetin), flavanones 
(naringenin glycosides, hesperitin glycosides), and isoflavones (genistein, dadzein, glycitein), 
all measured as glycosides [24, 25]. Other flavonoids were not available at this time and 
therefore not included in the current analysis. To assess diet quality, the Health Eating Index 
2010 was computed for study participants as described previously [26]. 
 
Laboratory assays. To evaluate the association between polyphenol intake and serum 
concentrations of selected adipokines and inflammatory markers, we included 1287 controls 
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from nested case-control studies on non-Hodgkin lymphoma [27] and breast cancer [28]. 
Several adipokines and inflammatory markers were measured in these studies, including pro-
inflammatory cytokines (interleukin [IL]-1 β, IL-6, IL-10, and tumor necrosis factor [TNF]-α), 
C-reactive protein (CRP), leptin, and adiponectin. All assays were performed by the Analytical 
Biochemistry Shared Resource at the University of Hawaii Cancer Center following the 
manufacturer's protocol unless noted otherwise [27, 28]. Frozen serum samples were 
retrieved from the MEC biorepository and analyzed in duplicate to quantify leptin and 
adiponectin using a double-antibody enzyme-linked-immunosorbent-assay (R&D Systems, 
Minneapolis, MN, U.S.A.). CRP was assessed using a Cobas MiraPlus clinical chemistry analyzer 
(Roche Diagnostics, Indianapolis, IN) and a latex particle enhanced immunoturbidimetry-
based kit from Pointe Scientific (Lincoln Park, MI). TNF-α, IL-1β, IL-6, and IL-10 were included 
in a Luminex panel, measured using a modification of an Invitrogen (Carlsbad, CA) magnetic 
high sensitivity 10-plex assay (LHC0001), and quantified on a Luminex 200 plate reader. Intra-
batch coefficients of variation based on 96 blinded duplicate and 9 triplet samples for leptin, 
adiponectin, CRP, TNF-α, IL-1β, IL-6 and IL-10 were 3.4-6.4%, 2.5-9.4%, 3.5-5.0%, 10.0%, 
20.9%, 8.9%, and 7.8% respectively [27, 28]. 
 
Statistical analysis. Since dietary intake variables and serum biomarkers were not normally 
distributed, these variables were log-transformed to satisfy model assumptions. We used 
linear regression analysis to compute covariate-adjusted geometric mean concentrations of 
inflammatory markers and adipokines by tertiles of flavonoid (flavanones, flavonols, and 
isoflavones) intake. To evaluate trends, we modeled the flavonoids as log-transformed 
continuous variables. In all models, we took into account age at blood draw, sex, ethnicity, 
study indicator (breast or NHL), season of blood draw (October-March or April-September), 
total energy intake (log-transformed, continuous), body mass index (BMI, kg/m2, continuous, 
log-transformed), smoking status (never, past, current), physical activity (< vs. ≥1/2 hour 
moderate/vigorous activity per day), alcohol intake (<1 drink/month, ≥1/month and <1/day, 
≥1/day), and the Healthy Eating Index 2010 [26]. The models were also tested for interaction 
of flavonoids with ethnicity. Ethnic-specific analyses were conducted when a significant 
interaction term was detected. For 957 cohort members with Qx3 data, the overall models 
were repeated to examine if diet closer to blood draw results in different findings. All 
analyses were performed with SAS software, version 9.3 (SAS Institute Inc., Cary, North 
Carolina). 
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Results 
Of 1,287 study participants, 960 (74.6%) were female and 327 (25.4%) were male. The 
mean age at blood collection was 68.9 years, with men being slightly older than women. 
Approximately 25% of the participants were white, 32% Japanese American, 20% Latino, 16% 
African American, and 8% Native Hawaiian (Table 1). Mean time from cohort entry to blood 
draw was 9.6 years. Almost 50% of blood samples were collected during winter months. The 
prevalence of smoking at cohort entry was generally low, but differed among ethnic groups 
with the highest prevalence among African Americans (15.5%) and the lowest in Japanese 
Americans (6.3%). Median intakes of flavanones, flavonols, and isoflavones were 26.5, 12.4, 
and 1.3 mg/day, respectively. Intake of flavonols was similar across ethnic groups, whereas 
isoflavones and flavanone intake varied widely. Serum concentrations of inflammatory 
markers and adipokines also differed considerably across ethnic groups, with generally highest 
concentrations of inflammatory markers in African Americans and the lowest in Japanese 
Americans; the same was true for leptin levels. 
None of the flavonoids available for analysis was statistically significantly associated 
with serum concentrations of adipokines or inflammatory markers (Table 2) with the 
exception of flavanone intake, which was statistically significantly inversely associated with 
adiponectin (p=0.01) and IL-6 concentrations (p=0.04). When we examined the relation of 
flavonoids with adipokines and inflammatory markers by ethnic group, we generally observed 
no significant associations with the exception of statistically significant effect modification of 
the association between flavonol intake and IL-10 concentration (pinteraction= 0.04), but the 
association between flavonol intake and IL-10 concentration was not statistically significant in 
any racial/ethnic group after stratification (data not shown).  
 The mean time between Qx3 and blood draw was 2.0±2.6 years for the 957 
participants who completed Qx3; of these 861 donated blood before and 114 after Qx3. 
Median intakes at Qx3 were estimated as 17.0 (Q1, Q3: 5.2, 45.9) mg for flavanones, 12.9 
(7.6, 19.6) mg for flavonols, and 3.3 (0.9, 8.8) mg for isoflavones. The values at cohort entry 
and Qx3 were significantly correlated (p<0.0001 for all): flavonols (rs=0.49), flavanones 
(rs=0.43), and isoflavones (rs=0.58) despite the differences in medians. Diet quality as 
indicated by the HEI-2010 increased slightly from 69.8 to 74.4 from Qx1 to Qx3 and the 
correlation was comparable to the flavonoids (rs=0.49; p<0.0001). Using Qx3 data, the 
associations in the overall models were null for all models, even the p-values for trend of 
flavanones with adiponectin and IL-6 concentrations were non-significant (p=0.12 and 0.22, 
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respectively). Geometric mean concentrations by tertiles of flavanone intake were 7.9, 8.0, 
and 8.5 µg/mL for adiponectin and 3.3, 3.2 and 3.1 pg/mL for IL-6 (data not shown). 
Discussion 
In this multiethnic US cohort, dietary intake of different classes of flavonoids, i.e., 
flavanones, flavonols and isoflavones, measured at two points in time was generally not 
associated with circulating concentrations of adipokines and inflammatory markers. Very few 
statistically significant associations were detected, but there was no systematic pattern. 
Therefore, the multiple comparisons probably led to a few chance findings. Using dietary 
intake data closer to the blood draw (2 instead of 9 years) did not change the results 
substantially.  
Although flavonoids have been shown to be associated with inflammatory processes in 
vitro and in vivo [10], only a few epidemiological studies examined the associations of 
flavonoid intake with inflammation and reported significant associations in contrast to the 
current findings. In NHANES, intake of flavonols was inversely associated with CRP 
concentration, but there was no association with intake of flavanones [11]. In a UK study, 
intake of flavanones and flavonols was not associated with serum concentrations of 
adiponectin and CRP in a group of women aged 18-76 years [12]. In the Nurses' Health Study, 
intake of flavanones was related to lower IL-18 concentration and intake of flavonols with 
lower concentration of soluble vascular cell adhesion molecule-1, but neither flavanone 
intake nor flavonol intake was associated with concentrations of CRP, soluble tumor-necrosis 
factor-2 (sTNF-2), or IL-6 [13]. In the Women's Health Study, intake of flavonols was not 
associated with plasma concentrations of CRP or IL-6 [14]. 
Our results on soy isoflavones that may act as weak estrogens, antioxidants and/or 
anti-inflammatory agents [29] also disagree with published evidence. Dietary isoflavone 
intake was inversely associated with concentration of CRP in two reports [15, 30]; in NHANES, 
higher urinary excretion of isoflavones was related to lower CRP concentration and lower 
white blood cell count [16]. However, the results of intervention trials with isoflavones (as 
reviewed in Ref.[16]) and lignans [18, 19] were heterogeneous. In contrast to isoflavones, 
which are more common in Asian diets, lignans, another group of phytoestrogens, are 
predominantly part of Western diets. Only one study, also conducted in NHANES, examined 
the association of lignan excretion with inflammatory markers and described an inverse 
association with concentrations of CRP and white blood cell count [17].  
Strengths of this study include its multiethnic population and the population-based 
design. This allows for generalization of our results to non-white populations. Some 
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limitations need to be taken into account. First, blood samples were taken approximately 9 
years after cohort entry, but the associations remained null in a subset of participants who 
provided an updated diet history within 2 years of the blood draw, however, mostly after the 
blood draw. As indicated by the correlations of the flavonoid values and the diet quality 
indicator (Hei-2010) between Qx1 and Qx3, dietary intake remained fairly stable over time, 
an observation that agrees with reports that dietary habits in adults usually do not change 
much, even over longer periods of time [31]. Second, we did not have data on the intake of 
lignans and other flavonoids available in our database. Third, isoflavones are metabolized into 
more active components by gut microbiota, the patterns of which differ across individuals 
[32]. For this reason and because circulating concentrations are independent of measurement 
errors due to imprecise dietary assessment and databases [33], measuring circulating 
concentrations of isoflavones and other flavonoids as biomarkers might provide a better 
assessment of active components than estimating dietary intake [34, 35]. However, it has 
been shown that FFQs provide a reasonable estimate of true biological exposure [36, 37]. 
Other weaknesses include the lack of a better measure for visceral fat than BMI, e.g., waist-
hip ratio, which was not available. It is worthwhile to conduct similar analyses as our but with 
measured intake and circulating concentrations of flavonoids in order to (a) examine the 
association between intake and metabolism and (b) address the effect on inflammation. 
In conclusion, our FFQ-based results do not indicate that the habitual dietary intake of 
certain groups of flavonoids, including isoflavones, affects circulating concentrations of 
adipokines and cytokines in this population-based cohort of older adults with different ethnic 
backgrounds. Due to the possible role of the gut microbiome in polyphenol metabolism [32], 
very short-term exposure may be the most relevant to answer this question, In that case, 
possible associations need to be examined when the time period between diet history and 
blood draw is much shorter than in the current investigation.   
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Table 1. Characteristics of study participants by ethnic group1 
 
Characteristic All African American Native Hawaiian Japanese American Latino White 
Number of participants, % by ethnicity 1,287 15.5 7.9 31.9 20.1 24.7 
Female participants, % 74.6 72.5 82.2 78.3 76.7 67.0 
Current smoking at cohort entry2 9.5 15.5 10.9 6.3 7.4 11.0 
Diabetes at cohort entry, % 6.8 7.5 7.9 7.8 11.2 1.3 
Age at blood draw, years 68.9 (62.7, 74.5) 69.6 (65.0, 75.0) 65.8 (62.0, 72.0) 69.5 (61.7, 74.9) 68.2 (63.2, 73.3) 69.0 (62.0, 76.0) 
Time cohort entry to blood draw, years 9.6 (8.2, 10.8) 9.4 (6.5, 11.0) 9.2 (7.1, 10.5) 9.7 (8.7, 10.7) 9.3 (7.3, 10.2) 10.1 (8.7, 11.5) 
BMI at cohort entry, kg/m2 25.4 (22.6, 28.7) 27.5 (24.2, 31.1) 27.3 (24.9, 30.6) 23.5 (21.5, 26.2) 27.5 (24.3, 30.1) 24.5 (22.4, 27.8) 
Fasting hours before blood draw2  13.0 (11.3, 14.0) 13.3 (10.2, 15.0) 12.8 (11.6, 14.0) 13.0 (11.5, 14.0) 13.0 (11.0, 14.5) 12.8 (11.7, 13.6) 
Blood collected October-March, % 46.5 51.5 47.5 47.6 42.3 45.0 
Serum biomarker concentration       
   Leptin, ng/mL2 14.9 (7.6, 28.5) 26.4 (10.3, 49.4) 20.2 (12.3, 35.1) 10.5 (5.8, 17.9) 18.6 (10.9, 36.2) 14.3 (6.4, 28.6) 
   Adiponectin, µg/mL 8.9 (5.3, 14.7) 7.5 (3.9, 12.9) 7.4 (5.1, 11.7) 7.7 (4.7, 13.9) 9.9 (6.4, 15.2) 10.8 (6.5, 18.8) 
   C-reactive protein, mg/L2 1.8 (0.8, 4.0) 3.3 (1.6, 6.8) 2.2 (0.8, 3.7) 1.0 (0.4, 2.1) 2.5 (1.4, 4.9) 2.0 (1.0, 4.0) 
   TNF-α, pg/mL 6.7 (2.5, 14.0) 7.6 (2.3, 14.6) 8.2 (2.9, 16.3) 6.5 (3.0, 12.9) 7.2 (2.0, 15.4) 6.0 (2.2, 12.5) 
   Interleukin-1β, pg/mL 1.3 (0.7, 2.3) 1.3 (0.7, 2.8) 1.2 (0.6, 2.0) 1.3 (0.8, 2.2) 1.4 (0.7, 2.6) 1.2 (0.6, 2.1) 
   Interleukin-6, pg/mL 2.8 (1.3, 5.5) 3.3 (1.6, 7.4) 3.4 (1.9, 5.6) 2.5 (1.2, 4.7) 3.1 (1.5, 5.4) 2.5 (1.2, 5.1) 
   Interleukin-10, pg/mL 1.8 (0.8, 3.6) 1.7 (0.9, 3.9) 2.3 (1.1, 3.5) 1.9 (0.9, 3.7) 1.7 (0.8, 3.5) 1.5 (0.7, 3.7) 
Daily dietary intake at cohort entry       
Isoflavones, mg 1.3 (0.6, 3.5) 0.5 (0.2, 0.9) 2.9 (1.5, 5.6) 3.9 (2.5, 8.0) 0.9 (0.5, 1.4) 0.8 (0.4, 1.6) 
   Genistein, mg 0.7 (0.3, 1.7) 0.2 (0.1, 0.4) 1.4 (0.7, 2.7) 1.9 (1.2, 3.8) 0.4 (0.2, 0.7) 0.4 (0.2, 0.8) 
   Daidzein, mg 0.6 (0.2, 1.4) 0.2 (0.1, 0.4) 1.2 (0.6, 2.3) 1.6 (1.0, 3.2) 0.4 (0.2, 0.6) 0.3 (0.2, 0.7) 
   Glycitein, mg 0.1 (0.1, 0.4) 0.0 (0.0, 0.1) 0.3 (0.2, 0.7) 0.4 (0.3, 0.9) 0.1 (0.0, 0.1) 0.1 (0.0, 0.2) 
Flavonols, mg 12.4 (7.9, 18.7) 11.0 (7.2, 16.7) 12.4 (7.7, 18.3) 13.3 (8.2, 19.6) 12.6 (8.3, 20.2) 11.7 (7.5, 18.6) 
   Kaempferol, mg 2.9 (1.7, 5.0) 3.0 (1.7, 5.1) 3.3 (2.1, 5.1) 3.5 (2.2, 5.6) 2.3 (1.3, 4.0) 2.5 (1.6, 4.8) 
   Myricetin, mg 0.5 (0.3, 1.2) 0.4 (0.2, 0.7) 0.5 (0.2, 1.0) 0.6 (0.3, 1.3) 0.5 (0.2, 0.9) 0.6 (0.3, 1.4) 
   Quercetin, mg 8.8 (5.5, 12.6) 7.1 (5.0, 11.3) 8.6 (5.2, 11.6) 8.9 (5.6, 12.4) 9.9 (6.1, 14.4) 8.6 (5.6, 12.7) 
Flavanones, mg 26.5 (8.3, 63.6) 36.1 (11.0, 80.0) 18.1 (7.1, 55.5) 23.8 (7.1, 52.7) 33.2 (11.7, 82.1) 20.7 (7.5, 56.6) 
   Naringenin glycosides, mg 2.3 (0.5, 6.0) 3.3 (0.7, 6.7) 1.3 (0.2, 6.4) 1.8 (0.5, 5.6) 2.4 (0.7, 6.5) 2.3 (0.4, 6.2) 
   Hesperitin glycosides, mg 22.3 (7.0, 55.9) 31.7 (9.6, 72.8) 17.9 (6.1, 49.1) 19.2 (5.8, 47.8) 29.8 (10.2, 73.4) 17.7 (5.9, 46.2) 
Total energy, kcal/day 1827 (1380, 2443) 1654 (1230, 2420) 2037 (1358, 2504) 1798 (1418, 2385) 1926 (1354, 2789) 1825 (1409, 2348) 
Vegetables, g/day 296.3 (193.0, 426.0) 241.6 (167.7, 383.3) 336.0 (171.8, 452.3) 298.1 (198.6, 425.1) 319.3 (202.1, 483.1) 285.1 (198.5, 415.9) 
Fruits and fruit juice, g/day 291.7 (154.0, 477.9) 285.6 (145.6, 509.6) 263.0 (115.8, 518.7) 286.9 (148.9, 453.1) 318.2 (176.7, 544.2) 293.5 (170.6, 462.5) 
Dietary fiber, g/day 21.7 (15.1, 30.3) 21.0 (14.6, 29.9) 21.6 (12.4, 29.3) 20.3 (14.5, 26.7) 27.0 (16.5, 40.0) 22.0 (15.8, 29.7) 
Alcohol, g/day 0.0 (0.0, 3.7) 0.0 (0.0, 3.5) 0.0 (0.0, 4.0) 0.0 (0.0, 0.4) 0.0 (0.0, 2.2) 3.1 (0.0, 16.7) 
1 Data are given as median (interquartile range) or n (%); percentages may not add to 100 due to rounding.  
2 Data are missing for fasting hours prior to blood draw (N=18), current smoking at cohort entry (N=16), leptin (N=1), and C-reactive protein (N=6).  
  
  
Table 2. Serum concentrations of biomarkers1,2 by tertiles of dietary flavonoid intake at cohort entry, Multiethnic Cohort 
 
Analyte3 
 Leptin [ng/mL]  Adiponectin [µg/mL] 
 CRP [mg/mL]  TNF-α [pg/mL]  IL-6 [pg/mL]  IL-1β [pg/mL]  IL-10 [pg/mL] 
 
Geometric 
mean 95% CI  
Geometric 
mean 95% CI  
Geometric 
mean 2.195% CI  
Geometric 
mean 95% CI  
Geometric 
mean 95% CI  
Geometric 
mean 95% CI  
Geometric 
mean 95% CI 
Flavanones 
   T1 (4.7 mg/d) 12.8 (11.0, 14.9)  7.5 (6.3, 8.7)  2.1 (1.6, 2.6)  6.5 (4.8, 8.8)  2.8 (2.1, 3.8)  1.3 (1.0, 1.7)  2.2 (1.5, 3.1) 
   T2 (26.5 mg/d) 12.3 (10.5, 14.3)  7.4 (6.3, 8.7)  1.8 (1.4, 2.2)  6.1 (4.4, 8.3)  2.6 (1.9, 3.5)  1.3 (1.0, 1.7)  2.0 (1.3, 2.8) 
   T3 (86.3 mg/d) 12.0 (10.3, 14.0)  8.4 (7.2, 9.8)  2.0 (1.6, 2.5)  6.5 (4.8, 8.9)  3.1 (2.1, 4.1)  1.3 (1.0, 1.7)  2.1 (1.4, 3.0) 
p-trend4 0.51   0.01   0.33   0.32   0.04   0.30   0.35  
Flavonols 
   T1 (6.6 mg/d) 12.4 (10.6, 14.4)  8.2 (7.0, 9.6)  2.0 (1.6, 2.5)  6.4 (4.7, 8.7)  2.9 (2.1, 3.9)  1.4 (1.0, 1.8)  2.0 (1.4, 2.9) 
   T2 (12.4 mg/d) 12.7 (10.9, 14.8)  7.6 (6.5, 9.0)  1.9 (1.5, 2.4)  6.1 (4.4, 8.3)  2.7 (1.9, 3.6)  1.3 (0.9, 1.7)  2.0 (1.3, 2.8) 
   T3 (22.1 mg/d) 12.0 (10.3, 14.0)  7.6 (6.5, 8.9)  2.0 (1.5, 2.4)  6.5 (4.8, 8.8)  2.9 (2.1, 3.9)  1.3 (1.0, 1.7)  2.2 (1.5, 3.1) 
p-trend4 0.19   0.84   0.67   0.24   0.31   0.59   0.27  
Isoflavones 
   T1 (0.4 mg/d) 12.6 (10.8, 14.6)  7.9 (6.7, 9.2)  1.9 (1.5, 2.4)  6.3 (4.6, 8.5)  2.9 (2.1, 3.9)  1.3 (1.0, 1.7)  2.2 (1.5, 3.0) 
   T2 (1.3 mg/d) 12.4 (10.6, 14.6)  7.8 (6.6, 9.3)  2.1 (1.7, 2.7)  5.9 (4.2, 8.1)  2.6 (1.9, 3.6)  1.3 (1.0, 1.8)  2.2 (1.5, 3.1) 
   T3 (4.9 mg/d) 12.0 (10.2, 14.0)  7.6 (6.5, 9.0)  1.8 (1.4, 2.3)  6.8 (5.0, 9.3)  2.9 (2.1, 4.0)  1.3 (0.9, 1.7)  2.0 (1.3, 2.8) 
p-trend4 0.57   0.79   0.05   0.53   0.45   0.88   0.78  
1 Values are estimates from analysis of covariance of serum biomarkers; all serum biomarkers and dietary polyphenol intake were log-transformed. Data are missing for 
serum leptin (N=1), C-reactive protein (N=6). 
2 Geometric means were adjusted for age, sex, ethnicity, study, time of blood draw (October-March or April-September), total energy intake (log-transformed), BMI (log-
transformed), Healthy Eating Index-2010 (continuous), alcohol intake, physical activity, and smoking. 
3 Median intake (mg/day) within each tertile category (T1-T3) is presented in parenthesis. 
4 Trend test is based on log-transformed continuous flavonoid variable. 
 
